Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Porocarcinoma, Merkel cell carcinoma, or Sebaceous carcinoma (specific rare skin cancers)
- You have a type of skin melanoma (from sweat or oil glands) that is relatively thick, has grown to a certain depth, and shows signs of active cell division (confirm with trial site for exact measurements)
- You have melanoma of the conjunctiva (the surface of the eye), whether it is a new diagnosis or has come back, including cases linked to a pre-cancerous eye condition called primary acquired melanosis with atypia
- You have squamous cell cancer of the eye's glands or ducts that is at an advanced stage (Stage 3 or higher), has come back after treatment, or has spread along nearby nerves
- You have squamous cell cancer of the surface of the eye that is at Stage 3 or higher and/or has appeared in more than one area
- You are willing and able to sign a consent form to take part in the study
- There is no sign of cancer spread to nearby lymph nodes at the time of diagnosis (confirm with trial site)
Who may not be able to join:
- You are under 18 years of age
- Your cancer has already spread to other parts of the body (metastatic disease) when first diagnosed
- You do not meet the inclusion criteria listed above
- You are unable or unwilling to provide signed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0630154528
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of lymphoscintigraphic examination and SLN biopsy; Efficacy of lymphoscintigraphic examination and SLN biopsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.